{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T12:33:29Z","timestamp":1770554009781,"version":"3.49.0"},"reference-count":48,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1252,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:sec><jats:title>INTRODUCTION<\/jats:title><jats:p>Low doses of androgen are used in women for the symptomatic treatment of sexual dysfunction and premenstrual syndrome (PMS). However, little is known about the long\u2010term safety of androgen use in women. This study investigated the effects of low dose exogenous testosterone (T) on lipid metabolism, markers of activation of the coagulation system and ultrasonographic ovarian morphology in women.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS<\/jats:title><jats:p>Twenty\u2010two patients with severe PMS (age 39.6\u2003\u00b1\u20033.1 years, mean \u00b1\u2003SD) treated with subcutaneous T implants (100\u2003mg six monthly) for at least two years (mean duration 3.3 (\u00b10.9 years) were compared with 22 age\u2010matched (age 37.7\u2003\u00b1\u20032.9 years) control patients with severe PMS who had not previously received T treatment. All women continued to have regular menses.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS<\/jats:title><jats:p>Fasting blood samples were obtained for measurement of lipids and clotting factors and ovarian ultrasound examination carried out between days 1\u20134 of the menstrual cycle (2.3\u2003\u00b1\u20031.2 months after the T implant in T\u2010treated group).<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Mean plasma T was 4.5\u2003\u00b1\u20032.2\u2003nmol\/l, and 1.9\u2003\u00b1\u20030.6\u2003nmol\/l in the treated and control groups, respectively. In the T\u2010treated group apolipoprotein\u2010A1 (Apo\u2010A1) (treated 99.2\u2003\u00b1\u200312<jats:italic>vs<\/jats:italic>controls 116.2\u2003\u00b1\u200327.7\u2003g\/l,<jats:italic>P<\/jats:italic>\u2003&lt; 0.01) and high density lipoprotein cholesterol (HDL\u2010C) (treated 1.3\u2003\u00b1\u20030.3<jats:italic>vs<\/jats:italic>controls 1.5\u2003\u00b1\u20030.4\u2003nmol\/l,<jats:italic>P<\/jats:italic>\u2003&lt; 0.01) were significantly decreased. In addition very low density lipoprotein cholesterol (VLDL\u2010C) (treated 0.4\u2003\u00b1\u20030.3<jats:italic>vs<\/jats:italic>controls 0.2\u2003\u00b1\u20030.1\u2003nmol\/l,<jats:italic>P<\/jats:italic>\u2003&lt; 0.05) was increased in T\u2010treated patients. There were no differences in total serum cholesterol and triglyceride or low density lipoprotein cholesterol (LDL\u2010C), apolipoprotein B (Apo\u2010B), lipoprotein(a), lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein activity. There was no difference in clotting factors between the two groups which included prothrombin time, fibrinogen, antithrombin\u2010III, protein\u2010C, protein\u2010S (total and free), tissue plasminogen activator, plasminogen activator inhibitor, beta\u2010thromboglobulin and prothrombin fragments 1.2. Ultrasound showed normal ovarian architecture with no evidence of polycystic ovarian changes in any patients in the T\u2010treated group. \u2003No patient experienced adverse symptoms while on T treatment, in particular, there were no complaints of hirsutism or acne and no one requested termination of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>Low\u2010dose testosterome administration to women for over two years did not induce changes in ovarian architecture but had small, potentially atherogenic effects on some parameters of lipid and lipoprotein metabolism. However, no differences were detected in markers of activation of the clotting system to indicate an actual increase in the risk of thrombosis. Overall, this study provides largely reassuring data about the safety of low\u2010dose androgen treatment in women. However, caution should be exercised in women with existing or a familial predisposition to lipid abnormalities, because of the small but significant changes found in HDL\u2010C, apo\u2010A1 and VLDL\u2010C.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00525.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:37:36Z","timestamp":1047379056000},"page":"173-178","source":"Crossref","is-referenced-by-count":41,"title":["The effects of low\u2010dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women"],"prefix":"10.1111","volume":"49","author":[{"given":"H. M.","family":"Buckler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"McElhone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. N.","family":"Durrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. I.","family":"Mackness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Ludlam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. C. W.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92552-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(84)90078-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649799"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341107"},{"key":"e_1_2_6_6_2","first-page":"34","article-title":"The use of low dose testosterone implants in premenstrual syndrome","volume":"123","author":"Buckler H.M.","year":"1989","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(84)90008-2"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6577.936"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(90)90029-I"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(78)90634-9"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(92)90008-5"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(94)00898-H"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb03280.x"},{"key":"e_1_2_6_14_2","first-page":"116","article-title":"The effects of hormone implants on serum lipoproteins and steroid hormones in bilateral oophorectomised women","volume":"106","author":"Farish E.","year":"1984","journal-title":"Acta Endocrinology"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6804.694"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002153220716"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509283331307"},{"key":"e_1_2_6_18_2","first-page":"215","article-title":"Hormones and lipoproteins","volume":"2","author":"Furman R.H.","year":"1967","journal-title":"Progress in Biochemical Pharmacology"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90083-4"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0038-1661320","article-title":"Effect of stanazolol on factors 8 and 9 and serum aminotransferases in haemophilia","volume":"53","author":"Greer I.A.","year":"1985","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.9.1.136"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.61.2.302"},{"key":"e_1_2_6_23_2","first-page":"919","article-title":"A comparison of esterified estrogens with and without methyl testosterone: effects of endometrial histology ans serum lipoproteins in post\u2010menopausal women","volume":"82","author":"Hickok L.R.","year":"1993","journal-title":"Obstetrics and Gynecology"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/00926239308404885"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0038-1661049","article-title":"Stanazolol induced changes in fibrinolysis and coagulation in healthy adults","volume":"51","author":"Kluft C.","year":"1984","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-925"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-595X(86)80021-4"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00905.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","unstructured":"Mackness M.I.&Durrington P.N.(1991) Lipoprotein analysis for clinical studies. In:Lipoprotein Analysis A Practical Approach(eds. C.A. Converse & E.R. Skinner) pp.1\u201342. Oxford University Press Oxford.","DOI":"10.1093\/oso\/9780199631926.003.0001"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(92)90094-7"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.aje.a008725","article-title":"Association of sex hormones in adiposity with plasma levels of fibrinogen and PAI\u20101 in postmenopausal women","volume":"143","author":"Meilahn E.N.","journal-title":"American Journal of Epidemiology"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/206270a0"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a059384"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.1.37"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6869.61-c"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-199402000-00009"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(83)90002-1"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(88)90061-4"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(85)90009-5"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(87)90295-X"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198510243131703"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(93)90225-J"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365517109080184"},{"key":"e_1_2_6_44_2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.1989.03420080085036","article-title":"Contrasting effects of testosterone and stanazolol on serum lipoproteins","volume":"261","author":"Thompson P.D.","year":"1989","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/000456328402100516"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(94)00448-M"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-42-2-247"},{"key":"e_1_2_6_48_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinchem\/36.2.283","article-title":"Lipoprotein lipids in women with androgen excess. Independent associations with increased insulin and androgen","volume":"36","author":"Wild R.A.","year":"1990","journal-title":"Clinical Chemistry"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb02132.x"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00525.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00525.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00525.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T20:39:50Z","timestamp":1704314390000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00525.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00525.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00525.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}